glp 1 resistant food All about GLP-1! Whether you're taking a GLP-1 medication or not The Ultimate Guide to GLP-1:

Burke O, Sa B, Cespedes DA, Tosti A

For patients with persistent or unexplained digestive symptoms, breath testing can be a helpful diagnostic tool

Maintenance (week 17 onward, 2.4 mg): the dose carried through the 68-week trial endpoint

The role of other medications and supplements Many semaglutide users take other medications or supplements concurrently, and some of these can independently affect UTI risk

While real-world results may be slightly less, the improvements go beyond weight: Lower blood sugar, blood pressure, and triglycerides Reduced waist circumference and sleep apnea symptoms Better health-related quality of life Fewer major cardiovascular events Reduced progression of fatty liver disease and chronic kidney diseaseeven in the absence of weight loss (Mozaffarian et al., 2025)

Main results HbA1c, body weight, and FPG SGLT2i compared to placebo Four RCTs were included, with a total of 626 patients (304 in the SGLT2i group and 322 in the placebo group), which compared the changes in both HbA1c and body weight among patients with T2DM and low cardiovascular disease risk, from baseline to follow-up ( 2 = 0%) ( Figure 2A ) and body weight levels with low heterogeneity (MD: -1.32, 95% CI: -1.82, -0.82